Jabil Inc. - JBL STOCK NEWS

Jabil Inc. (NYSE: JBL) has declared a quarterly dividend of $0.08 per share, with shareholders of record as of August 15, 2022. The dividend is set to be paid on September 2, 2022. Jabil has a consistent history of dividend payments, having paid quarterly cash dividends since May 15, 2006. This ongoing commitment highlights the company's solid financial management and shareholder return strategy.

IdentifySensors Biologics has partnered with Jabil (NYSE: JBL) to manufacture portable diagnostic devices that detect infections molecularly with accuracy exceeding PCR tests. The Check4® devices include a multiple-use electronic reader and single-use test cartridges, capable of identifying four infections from saliva in minutes. This technology, developed in collaboration with Purdue University, enables real-time monitoring of test results at a lower cost than traditional methods. The partnership aims to ensure high-quality production of this innovative testing solution.

Jabil (NYSE: JBL) partners with SolarEdge to enhance manufacturing of intelligent power inverters and optimizers, achieving over 2.5 million inverters and 60 million optimizers globally. Their collaboration focuses on manufacturing automation and excellence, significantly reducing production time by nearly 50%. Jabil's dual-site strategy in China and Vietnam ensures scalability, while robust supply chain management mitigates disruptions, especially during the pandemic. This partnership aims to further the green energy revolution by delivering innovative solar solutions.

Jabil reported strong preliminary financial results for Q3 FY2022, with net revenue reaching $8.3 billion.

Year-on-year growth was noted in Diversified Manufacturing Services (up 7%) and Electronics Manufacturing Services (up 23%).

Operating income stood at $321 million with diluted EPS of $1.52. The fourth quarter outlook estimates revenue between $8.1 billion and $8.7 billion, with EPS projected between $1.78 and $2.18.

For FY2022, Jabil expects revenue around $32.8 billion and core EPS of $7.45.

Badger Technologies, a division of Jabil (NYSE: JBL), has launched a pilot program with Vallarta Supermarkets to enhance operational safety and customer service through multipurpose autonomous robots. These robots, deployed at five locations in California, assist in identifying hazards and enhancing inventory management. The program aims to improve store safety, cleanliness, and overall shopping experiences by automating hazard detection and providing real-time inventory data. Badger's robots are crucial in addressing labor shortages and improving operational efficiencies.

Jabil Inc. (NYSE: JBL) will release its third quarter fiscal year 2022 financial results on June 16, 2022, before the market opens. A conference call to discuss the results will take place at 8:30 a.m. ET on the same day. Investors can join the call by dialing (877) 407-6184 for the U.S. or (201) 389-0877 internationally. A live audio webcast and slide presentation will be available on Jabil's investor relations website, with an archived replay to follow.

Jabil announced a manufacturing collaboration with Cardo Systems, a leader in wireless communications for motorcyclists. This partnership enhances Jabil's capabilities in delivering over one million devices yearly, supported by its acoustics expertise and global supply chain. Cardo's products, including PACKTALK, utilize advanced technology for enhanced connectivity. The collaboration has led to significant growth, with Cardo experiencing 5X growth over five years. Key benefits include improved audio quality and reduced production costs, further solidifying Jabil's position in the manufacturing sector.

Jabil Healthcare has launched the Qfinity™ autoinjector platform, a reusable and modular solution for subcutaneous drug self-administration, offering up to 65% lower cost per injection compared to disposable market alternatives. This device handles over 100 injections and accommodates various pre-filled cassettes, addressing the critical issue of medical waste. In addition, the connected version, Qfinity+, allows remote patient monitoring at a 20% lower cost per injection. The platform's innovative design prioritizes sustainability and aims to reduce the healthcare industry's carbon footprint.